CliffBio
small molecule

PREDNISOLONE SODIUM PHOSPHATE

PREDNISOLONE SODIUM PHOSPHATE

Loss of exclusivity—loss of exclusivity
CompanyMISSION PHARMACAL CO

Drug detail

Brand namePREDNISOLONE SODIUM PHOSPHATE
Active ingredientPREDNISOLONE SODIUM PHOSPHATE
StrengthEQ 25MG BASE/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2010
Marketing statusRX

More from MISSION PHARMACAL CO

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

PREDNISOLONE SODIUM PHOSPHATE patent cliff — loss of exclusivity — | CliffBio